Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic

June 24, 2021 updated by: Anna Stigsdotter Neely, Umeå University

Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic: A Feasibility Study

Dance as a treatment to support physical, cognitive and emotional functioning, has gained increased acceptance as a healthcare intervention for people with Parkinson's Disease (PD). The impact of the COVID-19 pandemic has been far reaching with devastating effects for at-risk populations. To find alternative and safe treatment delivery options during the pandemic has been of outmost importance.

This mixed-methods, feasibility study on digital for people with Parkinson's Disease aimed to investigate: (1) the feasibility and safety of a digital home-based dance intervention for people with PD; (2) change in self-reported quality of life, cognitive complaints, psychological health and fatigue; and (3) the experience of digital dance for people with PD.

Twenty-three participants partook in 10 weekly digital dance classes at home via zoom. Feasibility outcomes measures were administered at post-test. Pre-post changes in self-reported quality of life, cognitive complaints, psychological health and fatigue were measured, as well as the experience of digital dance via focus groups.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

33

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden
        • Balettakademien

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Self-reported diagnosis of Parkinson's Disease
  • Participant in Dance for PD at Balettakademien, Stockholm, Sweden

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: digital dance for PD
The digital dance class was held via Zoom. The class was scheduled once a week for 60 min and consisted of 10 sessions. A professional, certified Dance for PD and experienced dance instructor was teaching the dance class. The dance classes followed the Dance for PD protocol yet was adjusted to fit the digital zoom format.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility outcome measures
Time Frame: Assessed at post-test

The following feasibility outcome measures were assessed: (a) Technical and safety issues, (b) Compliance and motivation, (c) Self-assessed improvement in physical function, wellbeing and cognitive function and (d) The importance of dance as an artistic and creative activity.

Each feasibility outcome measure was assessed via a 5-point Likert scale ranging from (1=very unsatisfactory, 5=very satisfactory), (1=not motivated, 5=very motivated), (1=noticeable worsening, 5=noticeable improvement) or (1=not meaningful, 5=very meaningful). Furthermore, each feasibility outcome measure had an open-ended question connected to it in order to capture any details related that feasibility domain. Two open-ended questions regarding positive and negative aspects of digital dancing were also included.

For each feasibility outcome measure, a criterion of success was developed in order to judge the the success rate of these feasibility outcome measures.

Assessed at post-test

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depression and anxiety
Time Frame: 12 weeks (pretest - posttest)
Severity of depression and anxiety symptoms measured by Hospital Anxiety Depression scale Anxiety score: 0-21 higher score indicate more anxiety Depression score: 0-21 higher score indicate more depression
12 weeks (pretest - posttest)
Quality of life (QoL) Summary index
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39), Summary index: 0-100 higher scores indicate more problems.

Furthermore, scores on the following subscales were assessed:

  • Mobility score: 0-100 higher scores indicate more problems
  • Activity of Daily Living score: 0-100 higher scores indicate more problems
  • Emotional well being score: 0-100 higher scores indicate more problems
  • Stigma score: 0-100 higher scores indicate more problems
  • Social support score: 0-100 higher scores indicate more problems
  • Cognition score: 0-100 higher scores indicate more problems
  • Communication score: 0-100 higher scores indicate more problems
  • Bodily discomfort score: 0-100 higher scores indicate more problems
12 weeks (pretest - posttest)
Quality of life (QoL) - Bodily discomfort
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Bodily discomfort score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Communication
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Communication score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Cognition
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale:Cognition score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Social support
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Social support score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Stigma
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Stigma score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Emotional well being
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Emotional well being score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) Activity of Daily Living
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale: Activity of Daily Living score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Quality of life (QoL) - Mobility
Time Frame: 12 weeks (pretest - posttest)

Quality of life measured by Parkinson's Disease Questionnaire-39 (PDQ39).

Subscale Mobility score: 0-100 higher scores indicate more problems

12 weeks (pretest - posttest)
Fatigue
Time Frame: 12 weeks (pretest - posttest)
Fatigue measured by Checklist Individual Strength Questionnaire (CIS). Total score: 20-140
12 weeks (pretest - posttest)
Subjective cognitive complaints
Time Frame: 12 weeks (pretest - posttest)
Improvement on subjective memory complaints measured by Prospective Retrospective Memory Questionnaire (PRMQ). Total score: 16-80 higher scores indicate more cognitive complaints prospective score: 0-100 higher scores indicate more cognitive complaints retrospective score: 0-100 higher scores indicate more cognitive complaints short term score: 0-100 higher scores indicate more cognitive complaints long term score: 0-100 higher scores indicate more cognitive complaints self cued score: 0-100 higher scores indicate more cognitive complaints environmentally cued: 0-100 higher scores indicate more cognitive complaints
12 weeks (pretest - posttest)
Mental fatigue
Time Frame: 12 weeks (pretest - posttest)
Two questions from the Mental Fatigue Scale were used to measure mental fatigue (item 3) and recovery (item 4). Answers were given on a 7-point Likert scale.
12 weeks (pretest - posttest)
Experience and meaning of digital dance for people with PD
Time Frame: Assessed at post-test
Two focus group interviews were conducted to examine the broader experience of digital dance for people with PD.
Assessed at post-test

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age
Time Frame: Assessed at pre-test
Demographic characteristic: age at baseline
Assessed at pre-test
Sex
Time Frame: Assessed at pre-test
Demographic characteristic: sex
Assessed at pre-test
Educational level
Time Frame: Assessed at pre-test
Demographic characteristic: educational level
Assessed at pre-test
Previous experience of dance for Parkinson's Disease
Time Frame: Assessed at pre-test
Demographic characteristic: previous experience of dance for PD
Assessed at pre-test
Self-evaluated health
Time Frame: Assessed a pre-test
Demographic characteristic: self-evaluated health
Assessed a pre-test
Disease duration
Time Frame: Assessed at pre-test
Demographic characteristic: self-reported year of PD diagnosis
Assessed at pre-test
Current participation in physical exercise
Time Frame: Assessed at pre-test
Demographic characteristic: current participation in physical exercise
Assessed at pre-test

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Anna S Neely, prof, Umea University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2020

Primary Completion (Actual)

December 3, 2020

Study Completion (Actual)

December 3, 2020

Study Registration Dates

First Submitted

June 23, 2021

First Submitted That Met QC Criteria

June 24, 2021

First Posted (Actual)

June 28, 2021

Study Record Updates

Last Update Posted (Actual)

June 28, 2021

Last Update Submitted That Met QC Criteria

June 24, 2021

Last Verified

June 1, 2021

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Digital dance for PD

3
Subscribe